Newsroom

Sorted by: Latest

-

Vietnam Airlines and FPT Strengthen Comprehensive Strategic Partnership to Advance Digital Aviation

HANOI, Vietnam--(BUSINESS WIRE)--Vietnam Airlines has signed a Memorandum of Understanding (MOU) with global technology corporation FPT to strengthen comprehensive strategic cooperation. The partnership aims to accelerate end-to-end digital transformation, enhance operational capabilities, and improve customer experience. Under the agreement, Vietnam Airlines and FPT will collaborate to co-design and implement a broad spectrum of advanced technology solutions, including Generative AI, Cloud Com...
-

New Two-year Follow-up of Genentech’s Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma Patients

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year follow-up data from the Phase III STARGLO study. After a median follow-up of 24.7 months, data showed a 40% improvement in overall survival (OS) for patients treated with Columvi® (glofitamab-gxbm) in combination with gemcitabine and oxaliplatin (GemOx) and median OS was not reached, compared to 13.5 months for Rituxan® (rituximab) plus GemOx (R-GemOx). The...
-

Curatis discloses Corticorelin as active substance of C-PTBE-01

LIESTAL, Switzerland--(BUSINESS WIRE)--An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster...
-

Résultats de l'Assemblée Générale mixte d'Innate Pharma du 22 mai 2025

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce les résultats du vote des actionnaires à l’Assemblée générale mixte qui s’est tenue à Marseille le 22 mai 2025. Toutes les résolutions ont été votées. 114 votes ont été enregistrés sur un total de 43 447 237 actions donnant droit à 43 535 215 droits de vote, soit un quorum de 47,14 %. L’Assemblée Générale Extraordinaire des actionnaires a notamment...
-

Outcome of Innate Pharma’s 2025 Annual General Meeting

MARSEILLE, France--(BUSINESS WIRE)--Outcome of Innate Pharma’s 2025 Annual General Meeting...
-

Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the presentation of long-term follow-up data from the Phase 2 TELLOMAK clinical trial evaluating lacutamab, an anti-KIR3DL2 monoclonal antibody, in patients with Sézary syndrome (SS) and mycosis fungoides (MF), two rare and aggressive forms of cutaneous T-cell lymphoma (CTCL). The results will be presented at the American Society of Clinical Oncol...
-

Innate Pharma met en avant des réponses durables de lacutamab dans le syndrome de Sézary et le mycosis fongoïde

Marseille--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui la présentation des données de suivi à long terme de l'essai clinique de Phase 2 TELLOMAK évaluant lacutamab, un anticorps monoclonal anti-KIR3DL2, chez des patients atteints d’un syndrome de Sézary ou d’un mycosis fongoïde, deux formes rares et agressives de lymphome cutané à cellules T. Les données seront présentées lors du congrès annuel 2025...
-

Somerset International Installs Six Tailings Dewatering Units at Warrior Met Coal’s Blue Creek Mine, the Largest U.S. Coal Facility Without a Tailings Dam

PITTSBURGH--(BUSINESS WIRE)--Somerset International has successfully deployed six state-of-the-art Tailings Dewatering systems at Warrior Met Coal’s Blue Creek Mine...
-

Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of the previously announced underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be issued and sold by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In add...
-

Smartly ajoute Reddit à sa plateforme publicitaire optimisée par l'IA

NEW YORK--(BUSINESS WIRE)--Smartly, la société de technologie publicitaire optimisée par l'IA reconnue comme un Leader dans The Forrester Wave™: Creative Advertising Technologies, annonce aujourd'hui l'intégration de Reddit dans sa plateforme unifiée. Ce lancement permet aux marques d’activer, de gérer et de mesurer les campagnes Reddit avec la même automatisation, l’intelligence créative et l’orchestration intercanal qui définissent l’approche de pointe de Smartly. Avec plus de 108 millions d'...